Tomkiel Melissa M. 4

What Happened
Melissa M. Tomkiel, Co-CEO, General Counsel and Director of Strata Critical Medical (SRTA), reported a disposition of 29,730 shares on 2026-06-08 at $5.87 per share, for a total reported value of $174,515. The filing indicates the shares were disposed to satisfy tax withholding obligations tied to the vesting of restricted stock units, not necessarily an open‑market sale for cash profit.

Key Details

• Transaction date and price: 2026-06-08, 29,730 shares at $5.87 each (total $174,515).
• Transaction type: Sale/disposition (SEC code S) recorded as shares withheld to cover taxes (footnote F1).
• Footnote: F1 — shares withheld by the issuer to satisfy tax withholding on vested RSUs.
• Filing date: 2026-06-10 (filed two days after the transaction); filing appears timely per Form 4 rules.
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context
This disposition reflects tax withholding on vested restricted stock units (a routine administrative transaction) rather than an independent decision to sell shares on the open market. Such withholdings are common and do not necessarily signal insider sentiment about the company’s prospects.